Advertisement
Advertisement
NSPR
InspireMD, Inc.
1.31
USDSponsored
-0.03
-2.31%
Apr 10, 15:59 UTC -4
Closed
After-Market
1.30
-0.01
-0.69%
NSPR Earnings Reports
Positive Surprise Ratio
NSPR beat 25 of 31 last estimates.
81%
Next Report
Date of Next Report
May 07, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.75M
/-$0.18
Implied change from Q4 25 (Revenue/ EPS)
-12.60%
/+28.57%
Implied change from Q1 25 (Revenue/ EPS)
+80.01%
/-18.18%
InspireMD, Inc. earnings per share and revenue
On Mar 18, 2026, NSPR reported earnings of -0.14 USD per share (EPS) for Q4 25, beating the estimate of -0.19 USD, resulting in a 29.01% surprise. Revenue reached 3.15 million, compared to an expected 2.68 million, with a 17.58% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 2.75 million USD, implying an increase of 28.57% EPS, and decrease of -12.60% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
What were InspireMD, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, InspireMD, Inc. reported EPS of -$0.14, beating estimates by 29.01%, and revenue of $3.15M, 17.58% above expectations.
How did the market react to InspireMD, Inc.'s Q4 2025 earnings?
The stock price moved -- 0%, changed from $1.79 before the earnings release to $1.79 the day after.
When is InspireMD, Inc. expected to report next?
The next earning report is scheduled for May 07, 2026.
What are the forecasts for InspireMD, Inc.'s next earnings report?
Based on 4
analysts, InspireMD, Inc. is expected to report EPS of -$0.18 and revenue of $2.75M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement